Company: AEMD
Filing Date: 2025-08-20
Form Type: S-1
Source: 0001683168-25-006352
Chunk: 59

Company: AETHLON MEDICAL INC
Filing Date: 2025-08-20
Form: S-1
Chunk 59
---
 stock, the holder of a pre-funded warrant does not have the rights or privileges of a holder of our common stock, including
any voting rights, until the holder exercises the pre-funded warrant.

Warrants

The following summary of certain
terms and provisions of the warrants offered hereby is not complete and is subject to, and qualified in its entirety by, the provisions
of the warrant, the form of which has been filed as an exhibit to the registration statement of which this prospectus is a part. Prospective
investors should carefully review the terms and provisions of the form of warrant for a complete description of the terms and conditions
of the warrants. In addition, the terms of the warrant to be issued to the placement agent will generally be the same as the warrants issued to investors in this offering, except that such warrant will not be exercisable for six months following theeffective date of the registration statement of which this prospectus forms a part.

Form. The warrants
will be issued as individual warrant agreements to the investors.

Exercisability. The
warrants are exercisable at any time after their original issuance, expected to be March , 2024, and at any time
up to the date that is five years after their original issuance. The warrants will be exercisable, at the option of each holder, in whole
or in part by delivering to us a duly executed exercise notice and, at any time a registration statement registering the issuance of the shares of common stock underlying the warrants under the Securities Act is effective and available for the issuance of such shares, or an exemption from registration under the Securities Act is available for the issuance of such shares,
by payment in full in immediately available funds for the number of shares of common stock purchased upon such exercise. If a registration statement registering the issuance of the shares of common stock underlying the warrants under the Securities Act is not effective or available and an exemption from registration under the Securities Act is not available for the issuance of such shares, the holder
may, in its sole discretion, elect to exercise the warrant through a cashless exercise, in which case the holder would receive upon such
exercise the net number of shares of common stock determined according to the formula set forth in the warrant. No fractional shares of
common stock will be issued in connection with the exercise of a warrant. In lieu of fractional shares, we will pay the holder an amount
in cash equal to the fractional amount multiplied by the exercise price.

Exercise Limitation.A
holder will not have the right to exercise any